Evidence map›Paper›PMID 26559764›Full record

ArticleBMC biotechnology2015

Use of next generation sequencing data to develop a qPCR method for specific detection of EU-unauthorized genetically modified Bacillus subtilis overproducing riboflavin.

Elodie Barbau-Piednoir, Sigrid C J De Keersmaecker, Maud Delvoye, Céline Gau, Patrick Philipp, Nancy H Roosens

Abstract read
In one paragraph

Article in BMC biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Metabolic Engineering ofMicroorganisms · 2023
    Review
  5. Retrospective surveillance of viableFrontiers in microbiology · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. EFSA statement on the risk posed to humans by a vitamin BEFSA journal. European Food Safety Authority · 2019
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elodie Barbau-PiednoirScientific Institute of Public Health (WIV-ISP), Platform Biotechnology and Molecular Biology, rue Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Elodie.piednoir@wiv-isp.be.
Sigrid C J De KeersmaeckerScientific Institute of Public Health (WIV-ISP), Platform Biotechnology and Molecular Biology, rue Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Sigrid.dekeersmaecker@wiv-isp.be.
Maud DelvoyeScientific Institute of Public Health (WIV-ISP), Platform Biotechnology and Molecular Biology, rue Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. maud.delvoye@wiv-isp.be.
Céline GauService Commun des Laboratoires, 13 chemin du routoir, 67400, Illkirch-Graffenstaden, France. Celine.GAU@scl.finances.gouv.fr.
Patrick PhilippService Commun des Laboratoires, 13 chemin du routoir, 67400, Illkirch-Graffenstaden, France. Patrick.PHILIPP@scl.finances.gouv.fr.
Nancy H RoosensScientific Institute of Public Health (WIV-ISP), Platform Biotechnology and Molecular Biology, rue Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Nancy.Roosens@wiv-isp.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the presence of an unauthorized genetically modified (GM) Bacillus subtilis bacterium overproducing vitamin B2 in a feed additive was notified by the Rapid Alert System for Food and Feed (RASFF). This has demonstrated that a contamination by a GM micro-organism (GMM) may occur in feed additives and has confronted for the first time,the enforcement laboratories with this type of RASFF. As no sequence information of this GMM nor any specific detection or identification method was available, Next GenerationSequencing (NGS) was used to generate sequence information. However, NGS data analysis often requires appropriate tools, involving bioinformatics expertise which is not alwayspresent in the average enforcement laboratory. This hampers the use of this technology to rapidly obtain critical sequence information in order to be able to develop a specific qPCRdetection method.

methodsData generated by NGS were exploited using a simple BLAST approach. A TaqMan® qPCR method was developed and tested on isolated bacterial strains and on the feed additive directly.

resultsIn this study, a very simple strategy based on the common BLAST tools that can be used by any enforcement lab without profound bioinformatics expertise, was successfully used toanalyse the B. subtilis data generated by NGS. The results were used to design and assess a new TaqMan® qPCR method, specifically detecting this GM vitamin B2 overproducing bacterium. The method complies with EU critical performance parameters for specificity, sensitivity, PCR efficiency and repeatability. The VitB2-UGM method also could detect the B. subtilis strain in genomic DNA extracted from the feed additive, without prior culturing step.

conclusionsThe proposed method, provides a crucial tool for specifically and rapidly identifying this unauthorized GM bacterium in food and feed additives by enforcement laboratories. Moreover, this work can be seen as a case study to substantiate how the use of NGS data can offer an added value to easily gain access to sequence information needed to develop qPCR methods to detect unknown andunauthorized GMO in food and feed.

Indexed as

Bacillus subtilisGenetic EngineeringHigh-Throughput Nucleotide SequencingOrganisms, Genetically ModifiedReal-Time Polymerase Chain ReactionRiboflavinSensitivity and SpecificitySequence Analysis, DNARiboflavin

Identifiers

PMID26559764
PMCPMC4642757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.